Application Information

This drug has been submitted to the FDA under the reference 022580/001.

Names and composition

"QSYMIA" is the commercial name of a drug composed of PHENTERMINE HYDROCHLORIDE and TOPIRAMATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022580/001 QSYMIA PHENTERMINE HYDROCHLORIDE; TOPIRAMATE CAPSULE, EXTENDED RELEASE/ORAL EQ 3.75MG BASE and 23MG
022580/002 QSYMIA PHENTERMINE HYDROCHLORIDE; TOPIRAMATE CAPSULE, EXTENDED RELEASE/ORAL EQ 7.5MG BASE and 46MG
022580/003 QSYMIA PHENTERMINE HYDROCHLORIDE; TOPIRAMATE CAPSULE, EXTENDED RELEASE/ORAL EQ 11.25MG BASE and 69MG
022580/004 QSYMIA PHENTERMINE HYDROCHLORIDE; TOPIRAMATE CAPSULE, EXTENDED RELEASE/ORAL EQ 15MG BASE and 92MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022580/001 QSYMIA PHENTERMINE HYDROCHLORIDE; TOPIRAMATE CAPSULE, EXTENDED RELEASE/ORAL EQ 3.75MG BASE and 23MG
022580/002 QSYMIA PHENTERMINE HYDROCHLORIDE; TOPIRAMATE CAPSULE, EXTENDED RELEASE/ORAL EQ 7.5MG BASE and 46MG
022580/003 QSYMIA PHENTERMINE HYDROCHLORIDE; TOPIRAMATE CAPSULE, EXTENDED RELEASE/ORAL EQ 11.25MG BASE and 69MG
022580/004 QSYMIA PHENTERMINE HYDROCHLORIDE; TOPIRAMATE CAPSULE, EXTENDED RELEASE/ORAL EQ 15MG BASE and 92MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved